Mayer Fishman
University of South Florida(US)Tampa General Hospital(US)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Renal and related cancers, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma(2017)842 cited
- → Lipid accumulation and dendritic cell dysfunction in cancer(2010)681 cited
- → Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology(2017)577 cited
- → All-trans-Retinoic Acid Improves Differentiation of Myeloid Cells and Immune Response in Cancer Patients(2006)557 cited
- → Kidney Cancer(2009)470 cited
- → Mechanism of All- Trans Retinoic Acid Effect on Tumor-Associated Myeloid-Derived Suppressor Cells(2007)415 cited
- → Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial